Related Articles
Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts
Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model
Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model
Sustained effect of continuous treatment with bevacizumab following bevacizumab in combination with chemotherapy in a human ovarian clear cell carcinoma xenograft model
Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts